Enteral nutrition is a risk factor for airway complications in subjects undergoing noninvasive ventilation for acute respiratory failure

M Kogo, K Nagata, T Morimoto, J Ito, Y Sato… - Respiratory …, 2017 - rc.rcjournal.com
BACKGROUND: Early enteral nutrition is recommended for mechanically ventilated patients
in several studies and guidelines. In contrast, the effects of early enteral nutrition on …

[HTML][HTML] Characteristics and prognostic impact of pneumonitis during systemic anti-cancer therapy in patients with advanced non-small-cell lung cancer

…, R Kato, T Morimoto, R Shimizu, Y Sato, M Kogo… - PLoS …, 2016 - journals.plos.org
Background Data on characteristics, outcomes, and prognosis of advanced non-small-cell
lung cancer (NSCLC) patients who develop pneumonitis during systemic anti-cancer therapy (…

A phase II study of low starting dose of afatinib as first-line treatment in patients with EGFR mutation-positive non-small-cell lung cancer (KTORG1402)

…, T Kawai, R Kagami, Y Washio, T Ishida, M Kogo… - Lung Cancer, 2019 - Elsevier
Objectives Afatinib is an effective treatment in patients who have epidermal growth factor
receptor (EGFR) mutation-positive non-small-cell lung cancer (NSCLC), but its toxicities often …

Longitudinal Changes and Association of Respiratory Symptoms with Preserved Ratio Impaired Spirometry (PRISm): The Nagahama Study

M Kogo, S Sato, S Muro, H Matsumoto… - Annals of the …, 2023 - atsjournals.org
Rationale: Subjects with preserved ratio impaired spirometry (PRISm) experience increased
respiratory symptoms, although they present heterogeneous characteristics. However, the …

[HTML][HTML] The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma

Y Sato, D Fujimoto, K Uehara, R Shimizu, J Ito, M Kogo… - BMC cancer, 2016 - Springer
Background This study aimed to assess the prognostic accuracy of serum CA 19-9 in patients
with advanced lung adenocarcinoma. Methods We retrospectively reviewed data of 246 …

Transformation to large cell neuroendocrine carcinoma as acquired resistance mechanism of EGFR tyrosine kinase inhibitor

M Kogo, R Shimizu, K Uehara, Y Takahashi, M Kokubo… - Lung Cancer, 2015 - Elsevier
Objectives Several different acquired resistance mechanisms to epidermal growth factor
receptor (EGFR)-tyrosine kinase inhibitor (TKI) therapy have been described. Although rare, the …

[HTML][HTML] Impacts of lipid-related metabolites, adiposity, and genetic background on blood eosinophil counts: the Nagahama study

…, N Tashima, S Terada, N Nomura, M Kogo… - Scientific Reports, 2021 - nature.com
Blood eosinophil count is a useful measure in asthma or COPD management. Recent
epidemiological studies revealed that body mass index (BMI) is positively associated with …

Ineligibility for the PACIFIC trial in unresectable stage III non-small cell lung cancer patients

…, D Fujimoto, H Kawachi, Y Sato, M Kogo… - Cancer Chemotherapy …, 2019 - Springer
Purpose Recently, based on results of the PACIFIC trial, durvalumab after chemoradiotherapy
(CRT) became the standard therapy for unresectable stage III non-small cell lung cancer (…

[HTML][HTML] Development of airflow limitation, dyspnoea, and both in the general population: the Nagahama study

M Kogo, S Sato, S Muro, H Matsumoto, N Nomura… - Scientific Reports, 2022 - nature.com
Subjects with subclinical respiratory dysfunction who do not meet the chronic obstructive
pulmonary disease (COPD) criteria have attracted attention with regard to early COPD …

Evaluation of elevated plasma fatty acids as relevant factors for adult-onset asthma: The Nagahama Study

…, H Matsumoto, K Nishi, S Terada, M Kogo… - Allergology …, 2024 - jstage.jst.go.jp
Background: Obesity and increased body mass index (BMI) are the known risk factors for
adult-onset asthma. Serum free fatty acid (FFA) and other blood lipid levels are generally …